The Performance of Cochlin-Tomoprotein Detection Test in the Diagnosis of Perilymphatic Fistula

• Published in: Audiology & neurotology Vol. 15; no. 3; pp. 168 - 174
• Main Authors: Ikezono, Tetsuo, Shindo, Susumu, Sekiguchi, Satomi, Morizane, Toshio, Pawankar, Ruby, Watanabe, Atsushi, Miura, Masakazu, Yagi, Toshiaki
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland Karger 01.03.2010; S. Karger AG
• Subjects: Amino Acid Sequence; Animals; Antibodies; Audiology; Biological and medical sciences; Ear diseases; Ear, auditive nerve, cochleovestibular tract, facial nerve: diseases, semeiology; Fenestration, Labyrinth; Fistula - diagnosis; Fistula - metabolism; Hearing loss; Humans; Labyrinth Diseases - diagnosis; Labyrinth Diseases - metabolism; Medical diagnosis; Medical sciences; Nervous system (semeiology, syndromes); Nervous system as a whole; Neurology; Non tumoral diseases; Original Paper; Otitis Media with Effusion - diagnosis; Otitis Media with Effusion - metabolism; Otorhinolaryngology. Stomatology; Perilymph - physiology; Rabbits - immunology; Sensitivity and Specificity; Vestibular Diseases - diagnosis; Vestibular Diseases - metabolism; Human; Specificity; Sensitivity; COCH gene; Cochlin isoform; Diagnostic accuracy; Perilymphatic fistula; Perilymph; Vertigo; Hearing loss; Cochlin tomoprotein; Performance evaluation; Nervous system diseases; Perilymph fistula; Auditory disorder; ENT; Equilibrium disorder; Accuracy; Gene; ENT disease; Diagnosis; Detection
• ISSN: 1420-3030; 1421-9700
• DOI: 10.1159/000241097

Background: Perilymphatic fistula (PLF), defined as an abnormal communication between the inner and middle ear, presents with a symptomatology of hearing loss and vestibular disorder that is indistinguishable from a number of other inner ear diseases. Methods of diagnosis remain controversial. We have previously shown that Cochlin-tomoprotein (CTP) is selectively detected in the perilymph. To establish a definite diagnostic test for PLF using CTP as a biochemical marker, we examined the diagnostic performance of the CTP detection test. Methods: CTP detection test was performed by Western blot using recombinant human CTP (rhCTP) as a spiked standard. We evaluated the specificity of the CTP detection test by testing non-PLF cases. To describe the limitations of the test, we tested samples from patients with middle ear infection. We also studied the stability of CTP protein by storing the samples at room temperature (25°C) or 4°C for 55 days. The effects of repeated freezing and thawing were also evaluated. Serially diluted perilymph was tested to find out the detection limit of CTP. Findings: We have established a standardized CTP detection test using high (0.27 ng) and low (0.13 ng) spiked standards of rhCTP in Western blotting. Middle ear lavages (MEL) from 54 of 55 non-PLF cases were negative in the CTP detection test, i.e. the specificity of the test is 98.2%. MEL from 43 out of 46 cases with chronic suppurative otitis media or middle ear cholesteatoma were negative for CTP. CTP is a stable protein and detection was not affected by the storage, or freezing and thawing. The detection limit of perilymph was 0.161 µl/lane in an average of 5 samples. Interpretation: CTP is a stable perilymph-specific protein, and this CTP detection could be the first clinically established diagnostic tool to detect PLF with a high specificity. PLF is surgically correctable by sealing the fistula. Appropriate recognition and treatment of PLF can improve hearing and balance in afflicted patients.